TSCGX
Price
$18.42
Change
-$0.24 (-1.29%)
Updated
Oct 7 closing price
Net Assets
136.16M
VEXPX
Price
$120.44
Change
-$1.45 (-1.19%)
Updated
Oct 7 closing price
Net Assets
20.56B
Interact to see
Advertisement

TSCGX vs VEXPX

Header iconTSCGX vs VEXPX Comparison
Open Charts TSCGX vs VEXPXBanner chart's image
Thrivent Small Cap Growth S
Price$18.42
Change-$0.24 (-1.29%)
VolumeN/A
Net Assets136.16M
Vanguard Explorer I
Price$120.44
Change-$1.45 (-1.19%)
VolumeN/A
Net Assets20.56B
TSCGX vs VEXPX Comparison Chart in %
View a ticker or compare two or three
VS
TSCGX vs. VEXPX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSCGX is a Hold and VEXPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 20.6B vs. TSCGX (136M). VEXPX pays higher dividends than TSCGX: VEXPX (0.38) vs TSCGX (0.00). TSCGX was incepted earlier than VEXPX: TSCGX (8 years) vs VEXPX (58 years). TSCGX (1.09) is less costly to investors than VEXPX (0.44). TSCGX is a more actively managed with annual turnover of: 67.00 vs. VEXPX (35.00). TSCGX has a lower initial minimum investment than VEXPX: TSCGX (2000) vs VEXPX (3000). TSCGX annual gain was more profitable for investors over the last year : 2.96 vs. VEXPX (0.76). TSCGX return over 5 years is better than : 21.42 vs. VEXPX (6.12).
TSCGXVEXPXTSCGX / VEXPX
Total Expense Ratio0.950.44216%
Annual Report Gross Expense Ratio1.090.44248%
Fund Existence8 years58 years-
Gain YTD1.1536.03719%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets136M20.6B1%
Annual Yield % from dividends0.000.38-
Returns for 1 year2.960.76390%
Returns for 3 years25.9929.3788%
Returns for 5 years21.426.12350%
Returns for 10 yearsN/A34.92-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMAGX93.13N/A
N/A
Amana Growth Investor
FBTTX30.64N/A
N/A
Fidelity Advisor Biotechnology M
WLCVX23.57N/A
N/A
Wilshire Large Company Value Instl
RYCMX45.91N/A
N/A
Rydex Russell 2000 1.5x Strategy C
ARILX16.52N/A
N/A
Aristotle Core Eq I